MYAH HICKS-WIGGINS: Open Payments
NPI 1861000150 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$221 in 10 payments from 8 companies in 2025. Trend: 2023 $886 · 2024 $628 · 2025 $221
Food & beverage: $221
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $55 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Verona Pharma, Inc. | 1 | $25 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Philips North America LLC | 1 | $14 |
Products named: DUPIXENT, NUCALA, OFEV, Ohtuvayre, LUMRYZ, ZERBAXA, Vest Therapy Und.
Industry payments across NC — which companies pay providers there.
